Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism

NCT02282150 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Adrenal Insufficiency

Interventions

DRUG: Hydrocortisone
DRUG: Plenadren

Sponsor

Ulla Feldt-Rasmussen